Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Cap-Assisted Resection Margin Assessment (CARMA) Technique After Polyp Resection: a Prospective Feasibility Study of a "Novel" Approach to Reduce Polyp Recurrence

NCT05099432 is registered in ClinicalTrials.gov with Princess Alexandra Hospital, Brisbane, Australia as lead sponsor.

NCT NCT05099432
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05099432 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Cap-Assisted Resection Margin Assessment (CARMA) Technique After Polyp Resection: a Prospective Feasibility Study of a "Novel" Approach to Reduce Polyp Recurrence
Lead sponsor
Princess Alexandra Hospital, Brisbane, Australia
Phase
Not applicable
Overall status
Recruiting
Start date
November 30, 2021
Completion date
November 30, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colonic polyp, colonic sessile serrated lesion